Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Daniel Sherbenou

Concepts (197)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
24
2026
310
8.600
Why?
Drug Resistance, Neoplasm
10
2026
889
2.090
Why?
Antibodies, Monoclonal
9
2024
1511
2.030
Why?
Immunoconjugates
3
2020
138
1.370
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
2025
128
1.250
Why?
Thalidomide
3
2024
43
1.090
Why?
Antineoplastic Combined Chemotherapy Protocols
8
2026
1996
1.020
Why?
Interferon Regulatory Factors
2
2024
45
0.970
Why?
Leukocyte Common Antigens
1
2026
86
0.950
Why?
Immunotherapy, Adoptive
2
2026
356
0.900
Why?
Proto-Oncogene Proteins c-myc
2
2024
157
0.900
Why?
Fusion Proteins, bcr-abl
4
2010
68
0.880
Why?
Osteolysis
1
2025
17
0.860
Why?
Immunoglobulin Light Chains
1
2025
52
0.850
Why?
Ikaros Transcription Factor
1
2024
23
0.830
Why?
Ribosomes
1
2025
195
0.800
Why?
Protein Kinase Inhibitors
7
2025
982
0.800
Why?
Piperazines
5
2010
367
0.780
Why?
Pyrimidines
5
2010
530
0.720
Why?
Protein Biosynthesis
2
2025
447
0.700
Why?
TOR Serine-Threonine Kinases
1
2025
454
0.700
Why?
Intercellular Adhesion Molecule-1
2
2024
132
0.670
Why?
Neoplasm Recurrence, Local
4
2024
1156
0.660
Why?
Hydrazines
1
2021
37
0.660
Why?
T-Lymphocytes
2
2026
2007
0.640
Why?
Cell Line, Tumor
9
2026
3538
0.640
Why?
Membrane Cofactor Protein
2
2018
14
0.640
Why?
Antineoplastic Agents
5
2024
2218
0.640
Why?
Protein Synthesis Inhibitors
1
2020
48
0.630
Why?
ADP-ribosyl Cyclase 1
4
2024
43
0.620
Why?
Hematopoietic Stem Cell Transplantation
3
2021
700
0.610
Why?
Triazoles
1
2021
190
0.590
Why?
Antibodies, Bispecific
3
2026
70
0.530
Why?
CD8-Positive T-Lymphocytes
1
2024
929
0.530
Why?
Antibodies, Neoplasm
2
2018
34
0.530
Why?
B-Cell Maturation Antigen
2
2026
17
0.450
Why?
Antineoplastic Agents, Immunological
1
2017
200
0.430
Why?
Medical Oncology
3
2026
344
0.400
Why?
Dexamethasone
3
2021
368
0.390
Why?
Immunotherapy
2
2017
669
0.380
Why?
Mutation
4
2010
4082
0.380
Why?
Humans
36
2026
145625
0.330
Why?
src Homology Domains
1
2010
34
0.310
Why?
Mice
9
2026
18266
0.300
Why?
Gene Expression Regulation, Neoplastic
3
2025
1429
0.300
Why?
Benzamides
6
2018
226
0.300
Why?
Imatinib Mesylate
5
2010
77
0.280
Why?
Xenograft Model Antitumor Assays
4
2020
928
0.280
Why?
Transplantation Conditioning
3
2020
191
0.270
Why?
Oligopeptides
2
2021
264
0.270
Why?
Cord Blood Stem Cell Transplantation
2
2020
103
0.270
Why?
Animals
12
2026
38030
0.270
Why?
Sequence Deletion
1
2008
190
0.260
Why?
Protein-Tyrosine Kinases
2
2008
429
0.260
Why?
Mutant Proteins
1
2007
103
0.240
Why?
Stem Cell Transplantation
1
2026
189
0.210
Why?
Waldenstrom Macroglobulinemia
1
2024
20
0.200
Why?
Bone Marrow
3
2020
308
0.190
Why?
Male
15
2026
73014
0.190
Why?
Cell Proliferation
5
2020
2497
0.180
Why?
Bridged Bicyclo Compounds, Heterocyclic
1
2025
291
0.180
Why?
Sequence Analysis, RNA
1
2025
441
0.180
Why?
Lymphoma, B-Cell
1
2024
149
0.180
Why?
Antibodies, Monoclonal, Humanized
2
2019
992
0.180
Why?
Lymphoma
1
2024
251
0.180
Why?
Single-Cell Analysis
1
2025
366
0.170
Why?
Neoplastic Stem Cells
1
2025
402
0.160
Why?
Sulfonamides
1
2025
592
0.160
Why?
Antibodies, Anti-Idiotypic
1
2020
50
0.160
Why?
Graft vs Host Disease
2
2020
280
0.160
Why?
Proteasome Inhibitors
1
2020
42
0.160
Why?
Biomarkers, Tumor
1
2007
1334
0.150
Why?
Drug Screening Assays, Antitumor
1
2020
194
0.150
Why?
Primary Cell Culture
1
2020
172
0.150
Why?
Heterografts
1
2020
143
0.150
Why?
Drug Synergism
1
2020
353
0.150
Why?
Transplantation, Homologous
1
2021
415
0.150
Why?
Aged
10
2026
26251
0.150
Why?
Tumor Cells, Cultured
1
2020
878
0.140
Why?
Endoribonucleases
1
2019
80
0.140
Why?
Thiotepa
1
2018
21
0.140
Why?
Prognosis
2
2025
4331
0.130
Why?
Clinical Trials as Topic
2
2017
1062
0.130
Why?
Phenotype
1
2026
3186
0.130
Why?
Middle Aged
10
2026
36359
0.130
Why?
Prostate
1
2018
159
0.130
Why?
Melphalan
1
2017
43
0.130
Why?
Female
13
2026
79080
0.130
Why?
Antigens, Neoplasm
1
2018
271
0.120
Why?
Neuroendocrine Tumors
1
2018
122
0.120
Why?
Drug Evaluation, Preclinical
1
2017
195
0.120
Why?
Chromosomes, Human, Pair 1
1
2016
81
0.120
Why?
Flow Cytometry
1
2020
1160
0.120
Why?
Protein Structure, Tertiary
3
2007
834
0.120
Why?
Gene Dosage
1
2016
146
0.120
Why?
Salvage Therapy
1
2017
163
0.120
Why?
Wnt Signaling Pathway
1
2018
211
0.110
Why?
Treatment Outcome
3
2021
11744
0.110
Why?
Immunologic Factors
1
2018
244
0.110
Why?
Adult
9
2026
40821
0.110
Why?
Combined Modality Therapy
1
2017
1269
0.100
Why?
Molecular Targeted Therapy
1
2017
446
0.100
Why?
Signal Transduction
3
2020
5234
0.090
Why?
Aged, 80 and over
4
2019
8351
0.090
Why?
Recurrence
3
2019
1125
0.080
Why?
Adenocarcinoma
1
2018
927
0.080
Why?
Prostatic Neoplasms
1
2018
972
0.080
Why?
Retrospective Studies
3
2026
17291
0.080
Why?
Immunoblotting
2
2008
294
0.080
Why?
Protein Kinases
1
2010
311
0.070
Why?
Tumor Microenvironment
2
2026
745
0.070
Why?
Precursor Cells, B-Lymphoid
1
2008
41
0.070
Why?
Follow-Up Studies
2
2008
5397
0.070
Why?
Philadelphia Chromosome
1
2007
18
0.060
Why?
Tyrosine
1
2008
217
0.060
Why?
Cell Line
2
2010
2809
0.060
Why?
Janus Kinase 2
1
2006
31
0.060
Why?
RNA, Neoplasm
1
2007
76
0.060
Why?
Myeloproliferative Disorders
1
2006
21
0.060
Why?
Codon
1
2007
92
0.060
Why?
DNA, Neoplasm
1
2007
160
0.060
Why?
Treatment Refusal
1
2007
98
0.060
Why?
Remission Induction
1
2007
308
0.060
Why?
Proto-Oncogene Proteins c-abl
1
2005
6
0.060
Why?
DNA Mutational Analysis
1
2007
409
0.060
Why?
Bone Marrow Transplantation
1
2006
298
0.060
Why?
Models, Molecular
1
2010
1571
0.050
Why?
src-Family Kinases
1
2005
93
0.050
Why?
Blast Crisis
1
2025
34
0.050
Why?
Protein Conformation
1
2008
914
0.050
Why?
Mutation, Missense
1
2006
331
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2007
973
0.050
Why?
Chromatography, High Pressure Liquid
1
2007
588
0.050
Why?
Survival Analysis
2
2018
1372
0.050
Why?
Phosphorylation
1
2008
1717
0.050
Why?
Cells, Cultured
1
2008
4112
0.040
Why?
B-Lymphocytes
1
2026
884
0.040
Why?
X-Box Binding Protein 1
1
2019
16
0.040
Why?
Bortezomib
1
2019
54
0.040
Why?
Cohort Studies
1
2010
6045
0.040
Why?
Unfolded Protein Response
1
2019
58
0.040
Why?
Stevens-Johnson Syndrome
1
2019
37
0.040
Why?
Androstenes
1
2018
16
0.040
Why?
Therapeutics
1
2018
14
0.040
Why?
RNA, Messenger
1
2007
2783
0.030
Why?
Macaca fascicularis
1
2018
70
0.030
Why?
Phenylthiohydantoin
1
2018
44
0.030
Why?
Antibody Affinity
1
2018
60
0.030
Why?
Endoplasmic Reticulum Stress
1
2019
120
0.030
Why?
Myeloablative Agonists
1
2018
23
0.030
Why?
Vidarabine
1
2018
32
0.030
Why?
Young Adult
2
2018
14240
0.030
Why?
Myocarditis
1
2019
102
0.030
Why?
Low Density Lipoprotein Receptor-Related Protein-6
1
2018
4
0.030
Why?
Longitudinal Studies
1
2026
3005
0.030
Why?
Fetal Blood
1
2020
325
0.030
Why?
Whole-Body Irradiation
1
2018
73
0.030
Why?
Drug Administration Schedule
1
2019
782
0.030
Why?
Nitriles
1
2018
211
0.030
Why?
Wnt Proteins
1
2018
131
0.030
Why?
Maximum Tolerated Dose
1
2017
216
0.030
Why?
Kaplan-Meier Estimate
1
2019
959
0.030
Why?
Administration, Oral
1
2019
867
0.030
Why?
Transplantation, Autologous
1
2017
303
0.030
Why?
Proportional Hazards Models
1
2019
1318
0.030
Why?
beta Catenin
1
2018
250
0.030
Why?
Recombinant Fusion Proteins
1
2018
662
0.030
Why?
Biopsy
1
2019
1073
0.030
Why?
Immunohistochemistry
1
2019
1709
0.030
Why?
Survival Rate
1
2019
2078
0.030
Why?
Hematopoietic Stem Cells
2
2006
432
0.020
Why?
Leukemia, Myeloid, Acute
1
2018
700
0.020
Why?
Disease Progression
1
2019
2857
0.020
Why?
Biomarkers
1
2019
4329
0.020
Why?
Hematopoiesis, Extramedullary
1
2006
5
0.020
Why?
Polycythemia Vera
1
2006
9
0.020
Why?
Receptors, Erythropoietin
1
2006
21
0.020
Why?
Polycythemia
1
2006
25
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
2006
90
0.020
Why?
Clone Cells
1
2006
259
0.010
Why?
Phosphotyrosine
1
2005
38
0.010
Why?
Erythropoietin
1
2006
100
0.010
Why?
Inhibitory Concentration 50
1
2005
90
0.010
Why?
Bone Marrow Cells
1
2006
326
0.010
Why?
Dasatinib
1
2005
58
0.010
Why?
Time Factors
2
2006
7079
0.010
Why?
Thiazoles
1
2005
139
0.010
Why?
Point Mutation
1
2005
232
0.010
Why?
Spleen
1
2006
503
0.010
Why?
Transfection
1
2006
914
0.010
Why?
Genetic Vectors
1
2005
326
0.010
Why?
Fibrosis
1
2006
568
0.010
Why?
Mice, Inbred BALB C
1
2006
1244
0.010
Why?
Adenosine Triphosphate
1
2005
494
0.010
Why?
Tumor Necrosis Factor-alpha
1
2006
1223
0.010
Why?
Dose-Response Relationship, Drug
1
2005
2018
0.010
Why?
Stem Cells
1
2005
612
0.010
Why?
Sherbenou's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)